|
$1,300,000
|
To support the purpose of developing and advancing a comprehensive set of policy options for intellectual property reform in the drug space through research, public education, and policy development.
|
2022 - 2024
|
LJAF
|
|
$600,000
|
To support the development of an outline of strategy and policy recommendations for federal patent reform.
|
2021 - 2022
|
LJAF
|
|
$70,000
|
To support efforts to provide key stakeholders and policymakers nonpartisan technical assistance and to educate the public about drug patents and high drug prices.
|
2021
|
LJAF
|
|
$3,958,828
|
To support efforts to provide patients with affordable access to life-saving medications and improve public health.
|
2017 - 2019
|
LJAF
|
|
$50,000
|
To support efforts to provide key stakeholders and policymakers nonpartisan technical assistance and educate the public about drug patents and high drug prices.
|
2021
|
LJAF
|
|
$209,500
|
To produce a report that will outline strategies to address pharmaceutical patents and pricing structures.
|
2016
|
LJAF
|
